ouch!_老虎社区_美港股上老虎

NeilTan
2021-04-13

ouch!

Johnson & Johnson dipped about 3% in premarket trading<blockquote>强生公司盘前交易下跌约3%</blockquote>

U.S. Calls For Pause On Johnson & Johnson Vaccine After Clotting Cases.KEY POINTSThe FDA said it is

Johnson & Johnson dipped about 3% in premarket trading<blockquote>强生公司盘前交易下跌约3%</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":345657451,"tweetId":"345657451","gmtCreate":1618312703073,"gmtModify":1634293794946,"author":{"id":3572922175988626,"idStr":"3572922175988626","authorId":3572922175988626,"authorIdStr":"3572922175988626","name":"NeilTan","avatar":"https://static.tigerbbs.com/d2ec928a37d3fc1d36b74903dc504957","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":37,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>ouch!</body></html>","htmlText":"<html><head></head><body>ouch!</body></html>","text":"ouch!","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/345657451","repostId":1178797310,"repostType":4,"repost":{"id":"1178797310","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1618312466,"share":"https://www.laohu8.com/m/news/1178797310?lang=zh_CN&edition=full","pubTime":"2021-04-13 19:14","market":"us","language":"en","title":"Johnson & Johnson dipped about 3% in premarket trading<blockquote>强生公司盘前交易下跌约3%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1178797310","media":"Tiger Newspress","summary":"U.S. Calls For Pause On Johnson & Johnson Vaccine After Clotting Cases.KEY POINTSThe FDA said it is ","content":"U.S. Calls For Pause On Johnson &amp; Johnson Vaccine After Clotting Cases.<blockquote>美国评级在出现凝血病例后暂停使用强生疫苗。</blockquote><img src=\"https://static.tigerbbs.com/44ed5a479ba7fa5976bb70090ba50c81\" tg-width=\"1242\" tg-height=\"2148\" referrerpolicy=\"no-referrer\"><blockquote></blockquote>KEY POINTS<blockquote>要点</blockquote><ul><li>The FDA said it is asking states to temporarily halt using J&amp;J’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.</li><li>The FDA said the recommendation is “out of an abundance of caution.”</li><li>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.</li></ul>The Food and Drug Administration said Tuesday it is asking states to temporarily halt usingJohnson &amp; Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.<blockquote><ul><li>FDA表示，在美国有六人出现罕见的凝血障碍后，要求各州暂时停止使用强生的Covid-19疫苗。</li><li>FDA表示，这一建议是“出于谨慎”。</li><li>所有六例病例均发生在年龄在18至48岁之间的女性中，症状在接受注射后6至13天出现。</li></ul>美国食品和药物管理局周二表示，在美国有六人出现罕见的凝血障碍后，要求各州暂时停止使用强生公司的Covid-19疫苗。</blockquote>The FDA said the recommendation is “out of an abundance of caution.”<blockquote>FDA表示，这一建议是“出于谨慎”。</blockquote>“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”<blockquote>FDA在与疾病控制与预防中心的联合声明中表示：“目前，这些不良事件似乎极其罕见。”“COVID-19疫苗安全是联邦政府的首要任务，我们非常认真地对待所有有关COVID-19疫苗接种后健康问题的报告。”</blockquote><img src=\"https://static.tigerbbs.com/b4808bfed9dcd9d1cc27ef92e3ba3dcf\" tg-width=\"512\" tg-height=\"232\">A White House spokesman referred CNBC to HHS when asked for comment.<blockquote>当被要求置评时，白宫发言人将CNBC转介给了HHS。</blockquote>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot. Doctors typically treat that type of blood clot with heparin but health regulators noted that could be dangerous in this case and recommended a different treatment.<blockquote>所有六例病例均发生在年龄在18至48岁之间的女性中，症状在接受注射后6至13天出现。医生通常用肝素治疗这种类型的血凝块，但卫生监管机构指出，在这种情况下这可能很危险，并建议采用不同的治疗方法。</blockquote>J&amp;J said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data.<blockquote>强生在一份声明中表示，血栓和疫苗之间“没有明确的因果关系”，并补充说正在与监管机构密切合作评估数据。</blockquote>People who receive the vaccine and “develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider,” the FDA and CDC said.<blockquote>FDA和CDC表示，接种疫苗并“在接种疫苗后三周内出现严重头痛、腹痛、腿痛或呼吸急促的人应联系他们的医疗保健提供者”。</blockquote>Shares of J&amp;J were down more than 3% in premarket trading Tuesday.<blockquote>周二盘前交易中，强生股价下跌超过3%。</blockquote>The CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review the cases, federal health regulators said Tuesday. The FDA is also investigating the cases.<blockquote>联邦卫生监管机构周二表示，疾病预防控制中心将于周三召开免疫实践咨询委员会会议，进一步审查这些病例。FDA也在调查这些病例。</blockquote>J&amp;J’s Covid-19 vaccine, like Pfizer’s and Moderna’s shots, received emergency use authorization from the FDA to start distributing the doses across the U.S. An EUA grants conditional clearance based on two months of safety data, pending full approval which usually requires at least six months of data.<blockquote>强生的新冠肺炎疫苗，像辉瑞和Moderna的疫苗一样，获得了FDA的紧急使用授权，开始在美国各地分发剂量。EUA根据两个月的安全数据授予有条件许可，等待完全批准，这通常需要至少六个月的数据。</blockquote>When J&amp;J submitted its Covid vaccine data to the FDA in February, no specific concerns were identified when analyzed by age, race and comorbidities, according to the agency. The FDA said at the time the most common side effects reported were headache and fatigue, followed by muscle aches, nausea and fever.<blockquote>据该机构称，当强生在2月份向FDA提交其Covid疫苗数据时，在按年龄、种族和合并症进行分析时，没有发现具体的问题。FDA当时表示，最常见的副作用是头痛和疲劳，其次是肌肉疼痛、恶心和发烧。</blockquote>The New York Timesfirst reportedthe news.<blockquote>《纽约时报》首先报道了这一消息。</blockquote>It’s unclear how the pause will impact J&amp;J’s goal to deliver 100 million doses to the U.S. by the end of May. The company has already been plagued by manufacturing issues of its vaccine.<blockquote>目前尚不清楚暂停将如何影响强生在5月底前向美国交付1亿剂疫苗的目标。该公司已经受到疫苗生产问题的困扰。</blockquote>Last week, Europe’s medicines regulatorsaid it found a possible linkbetween the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues. AstraZeneca has not received authorization for use in the U.S.<blockquote>上周，欧洲药品监管机构表示，发现阿斯利康和牛津大学开发的冠状病毒疫苗与罕见的凝血问题之间可能存在联系。阿斯利康尚未获得在美国使用的授权。</blockquote>Emer Cooke, executive director of the European Medicines Agency, said in a televised news conference last week that unusual blood clotting with low blood platelets would be added as a “very rare” side effect to the vaccine’s product information, along with a slew of other possible adverse reactions.<blockquote>欧洲药品管理局执行主任埃默·库克（Emer Cooke）在上周的电视新闻发布会上表示，血小板低的异常凝血将作为“非常罕见”的副作用添加到疫苗的产品信息中，同时还有一系列其他可能的不良反应。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Johnson & Johnson dipped about 3% in premarket trading<blockquote>强生公司盘前交易下跌约3%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJohnson & Johnson dipped about 3% in premarket trading<blockquote>强生公司盘前交易下跌约3%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\nTiger Newspress \n2021-04-13 19:14\n</div>\n</a>\n</h4>\n</header>\n<article>\nU.S. Calls For Pause On Johnson &amp; Johnson Vaccine After Clotting Cases.<blockquote>美国评级在出现凝血病例后暂停使用强生疫苗。</blockquote><img src=\"https://static.tigerbbs.com/44ed5a479ba7fa5976bb70090ba50c81\" tg-width=\"1242\" tg-height=\"2148\" referrerpolicy=\"no-referrer\"><blockquote></blockquote>KEY POINTS<blockquote>要点</blockquote><ul><li>The FDA said it is asking states to temporarily halt using J&amp;J’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.</li><li>The FDA said the recommendation is “out of an abundance of caution.”</li><li>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.</li></ul>The Food and Drug Administration said Tuesday it is asking states to temporarily halt usingJohnson &amp; Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.<blockquote><ul><li>FDA表示，在美国有六人出现罕见的凝血障碍后，要求各州暂时停止使用强生的Covid-19疫苗。</li><li>FDA表示，这一建议是“出于谨慎”。</li><li>所有六例病例均发生在年龄在18至48岁之间的女性中，症状在接受注射后6至13天出现。</li></ul>美国食品和药物管理局周二表示，在美国有六人出现罕见的凝血障碍后，要求各州暂时停止使用强生公司的Covid-19疫苗。</blockquote>The FDA said the recommendation is “out of an abundance of caution.”<blockquote>FDA表示，这一建议是“出于谨慎”。</blockquote>“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”<blockquote>FDA在与疾病控制与预防中心的联合声明中表示：“目前，这些不良事件似乎极其罕见。”“COVID-19疫苗安全是联邦政府的首要任务，我们非常认真地对待所有有关COVID-19疫苗接种后健康问题的报告。”</blockquote><img src=\"https://static.tigerbbs.com/b4808bfed9dcd9d1cc27ef92e3ba3dcf\" tg-width=\"512\" tg-height=\"232\">A White House spokesman referred CNBC to HHS when asked for comment.<blockquote>当被要求置评时，白宫发言人将CNBC转介给了HHS。</blockquote>All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot. Doctors typically treat that type of blood clot with heparin but health regulators noted that could be dangerous in this case and recommended a different treatment.<blockquote>所有六例病例均发生在年龄在18至48岁之间的女性中，症状在接受注射后6至13天出现。医生通常用肝素治疗这种类型的血凝块，但卫生监管机构指出，在这种情况下这可能很危险，并建议采用不同的治疗方法。</blockquote>J&amp;J said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data.<blockquote>强生在一份声明中表示，血栓和疫苗之间“没有明确的因果关系”，并补充说正在与监管机构密切合作评估数据。</blockquote>People who receive the vaccine and “develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider,” the FDA and CDC said.<blockquote>FDA和CDC表示，接种疫苗并“在接种疫苗后三周内出现严重头痛、腹痛、腿痛或呼吸急促的人应联系他们的医疗保健提供者”。</blockquote>Shares of J&amp;J were down more than 3% in premarket trading Tuesday.<blockquote>周二盘前交易中，强生股价下跌超过3%。</blockquote>The CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review the cases, federal health regulators said Tuesday. The FDA is also investigating the cases.<blockquote>联邦卫生监管机构周二表示，疾病预防控制中心将于周三召开免疫实践咨询委员会会议，进一步审查这些病例。FDA也在调查这些病例。</blockquote>J&amp;J’s Covid-19 vaccine, like Pfizer’s and Moderna’s shots, received emergency use authorization from the FDA to start distributing the doses across the U.S. An EUA grants conditional clearance based on two months of safety data, pending full approval which usually requires at least six months of data.<blockquote>强生的新冠肺炎疫苗，像辉瑞和Moderna的疫苗一样，获得了FDA的紧急使用授权，开始在美国各地分发剂量。EUA根据两个月的安全数据授予有条件许可，等待完全批准，这通常需要至少六个月的数据。</blockquote>When J&amp;J submitted its Covid vaccine data to the FDA in February, no specific concerns were identified when analyzed by age, race and comorbidities, according to the agency. The FDA said at the time the most common side effects reported were headache and fatigue, followed by muscle aches, nausea and fever.<blockquote>据该机构称，当强生在2月份向FDA提交其Covid疫苗数据时，在按年龄、种族和合并症进行分析时，没有发现具体的问题。FDA当时表示，最常见的副作用是头痛和疲劳，其次是肌肉疼痛、恶心和发烧。</blockquote>The New York Timesfirst reportedthe news.<blockquote>《纽约时报》首先报道了这一消息。</blockquote>It’s unclear how the pause will impact J&amp;J’s goal to deliver 100 million doses to the U.S. by the end of May. The company has already been plagued by manufacturing issues of its vaccine.<blockquote>目前尚不清楚暂停将如何影响强生在5月底前向美国交付1亿剂疫苗的目标。该公司已经受到疫苗生产问题的困扰。</blockquote>Last week, Europe’s medicines regulatorsaid it found a possible linkbetween the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues. AstraZeneca has not received authorization for use in the U.S.<blockquote>上周，欧洲药品监管机构表示，发现阿斯利康和牛津大学开发的冠状病毒疫苗与罕见的凝血问题之间可能存在联系。阿斯利康尚未获得在美国使用的授权。</blockquote>Emer Cooke, executive director of the European Medicines Agency, said in a televised news conference last week that unusual blood clotting with low blood platelets would be added as a “very rare” side effect to the vaccine’s product information, along with a slew of other possible adverse reactions.<blockquote>欧洲药品管理局执行主任埃默·库克（Emer Cooke）在上周的电视新闻发布会上表示，血小板低的异常凝血将作为“非常罕见”的副作用添加到疫苗的产品信息中，同时还有一系列其他可能的不良反应。</blockquote>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178797310","content_text":"U.S. Calls For Pause On Johnson & Johnson Vaccine After Clotting Cases.KEY POINTSThe FDA said it is asking states to temporarily halt using J&J’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.The FDA said the recommendation is “out of an abundance of caution.”All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.The Food and Drug Administration said Tuesday it is asking states to temporarily halt usingJohnson & Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.The FDA said the recommendation is “out of an abundance of caution.”“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”A White House spokesman referred CNBC to HHS when asked for comment.All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot. Doctors typically treat that type of blood clot with heparin but health regulators noted that could be dangerous in this case and recommended a different treatment.J&J said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data.People who receive the vaccine and “develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider,” the FDA and CDC said.Shares of J&J were down more than 3% in premarket trading Tuesday.The CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to further review the cases, federal health regulators said Tuesday. The FDA is also investigating the cases.J&J’s Covid-19 vaccine, like Pfizer’s and Moderna’s shots, received emergency use authorization from the FDA to start distributing the doses across the U.S. An EUA grants conditional clearance based on two months of safety data, pending full approval which usually requires at least six months of data.When J&J submitted its Covid vaccine data to the FDA in February, no specific concerns were identified when analyzed by age, race and comorbidities, according to the agency. The FDA said at the time the most common side effects reported were headache and fatigue, followed by muscle aches, nausea and fever.The New York Timesfirst reportedthe news.It’s unclear how the pause will impact J&J’s goal to deliver 100 million doses to the U.S. by the end of May. The company has already been plagued by manufacturing issues of its vaccine.Last week, Europe’s medicines regulatorsaid it found a possible linkbetween the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues. AstraZeneca has not received authorization for use in the U.S.Emer Cooke, executive director of the European Medicines Agency, said in a televised news conference last week that unusual blood clotting with low blood platelets would be added as a “very rare” side effect to the vaccine’s product information, along with a slew of other possible adverse reactions.","news_type":1,"symbols_score_info":{"JNJ":0.9}},"isVote":1,"tweetType":1,"viewCount":1566,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}

Johnson & Johnson dipped about 3% in premarket trading<blockquote>强生公司盘前交易下跌约3%</blockquote>

评论（2）

热议股票